Insider · CIK 0001504466

Maples Kirk R

Reports to the SEC for 1 company · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001504466

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-06-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−500 sh	$70.03	−$35K	7,320
2015-06-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−100 sh	$71.72	−$7,172	7,220
2015-05-12	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+6,060 sh	$6.92	+$41.9K	13,880
2015-05-12	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−4,900 sh	$60.97	−$299K	8,980
2015-05-12	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−1,160 sh	$61.50	−$71.3K	7,820
2015-05-12	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−6,060 sh	—	—	12,148
2015-05-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−100 sh	$52.99	−$5,299	8,320
2015-05-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−500 sh	$54.14	−$27.1K	7,820
2015-04-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$57.02	−$34.2K	8,420
2015-03-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$43.95	−$26.4K	9,020
2015-02-03	Anacor Pharmaceuticals, Inc.A Award	SVP, Program Management	AAward	+5,020 sh	—	—	9,620
2015-02-03	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, Program Management	AAward	+20.8K sh	—	—	20,845
2015-02-03	Anacor Pharmaceuticals, Inc.Performance Restricted Stock UnitsA Award	SVP, Program Management	AAward	+1,475 sh	—	—	1,475
2015-02-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$37.41	−$22.4K	4,600
2015-01-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$31.96	−$19.2K	4,200
2014-12-09	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+19.9K sh	$6.92	+$138K	24,696
2014-12-09	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−19.9K sh	$36.52	−$727K	4,800
2014-12-09	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+40.1K sh	$5.59	+$224K	44,904
2014-12-09	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−40.1K sh	$36.52	−$1.46M	4,800
2014-12-09	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−19.9K sh	$6.92	−$138K	18,208
2014-12-09	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−40.1K sh	$5.59	−$224K	14,896
2014-12-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−500 sh	$33.24	−$16.6K	4,900
2014-12-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−100 sh	$34.03	−$3,403	4,800
2014-11-03	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$29.09	−$17.5K	5,400
2014-10-01	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$23.85	−$14.3K	6,000
2014-09-02	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+9,860 sh	$5.00	+$49.3K	18,154
2014-09-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−9,860 sh	$23.30	−$230K	8,294
2014-09-02	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+22.3K sh	$7.25	+$162K	30,619
2014-09-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−22.3K sh	$23.30	−$520K	8,294
2014-09-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−1,000 sh	$23.34	−$23.3K	7,294
2014-09-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−94 sh	$23.34	−$2,193.96	7,200
2014-09-02	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−600 sh	$23.32	−$14K	6,600
2014-09-02	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−9,860 sh	$5.00	−$49.3K	0
2014-09-02	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−22.3K sh	$7.25	−$162K	8,654
2014-08-13	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+1,000 sh	$7.25	+$7,250	2,000
2014-08-13	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−367 sh	$19.96	−$7,324.403	1,633
2014-08-13	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+10.3K sh	$6.92	+$71K	11,886
2014-08-13	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−3,592 sh	$19.96	−$71.7K	8,294
2014-08-13	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−1,000 sh	$7.25	−$7,250	30,979
2014-08-13	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	−10.3K sh	$6.92	−$71K	38,104
2014-03-20	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−2,381 sh	$22.29	−$53.1K	5,239
2014-03-20	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−619 sh	$22.77	−$14.1K	4,620
2014-02-20	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−3,000 sh	$19.33	−$58K	7,620
2014-02-07	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, Program Management	AAward	+47K sh	—	—	47,000
2014-01-21	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−3,000 sh	$20.27	−$60.8K	9,620
2013-12-20	Anacor Pharmaceuticals, Inc.S Sale	SVP, Program Management	SSale	−3,000 sh	$16.73	−$50.2K	12,620
2013-11-25	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+3,664 sh	$5.00	+$18.3K	3,664
2013-11-25	Anacor Pharmaceuticals, Inc.F Tax Payment	SVP, Program Management	FTax Payment	−1,447 sh	$12.78	−$18.5K	2,217
2013-11-25	Anacor Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Program Management	MExercise/Conversion	+14.4K sh	$7.55	+$109K	16,592
2013-11-25	Anacor Pharmaceuticals, Inc.F Tax Payment	SVP, Program Management	FTax Payment	−8,568 sh	$12.78	−$110K	8,024

Recent filings

Accepted (ET)
Jun 24
Anacor Pharmaceuticals, Inc.0001209191-15-049207
SEC(opens sec.gov)
May 144
Anacor Pharmaceuticals, Inc.0001209191-15-043018
SEC(opens sec.gov)
May 14
Anacor Pharmaceuticals, Inc.0001209191-15-038191
SEC(opens sec.gov)
Apr 34
Anacor Pharmaceuticals, Inc.0001209191-15-032245
SEC(opens sec.gov)
Mar 44
Anacor Pharmaceuticals, Inc.0001209191-15-022570
SEC(opens sec.gov)
Feb 54
Anacor Pharmaceuticals, Inc.0001209191-15-010084
SEC(opens sec.gov)
Feb 44
Anacor Pharmaceuticals, Inc.0001209191-15-009386
SEC(opens sec.gov)
Jan 64
Anacor Pharmaceuticals, Inc.0001209191-15-002191
SEC(opens sec.gov)
Dec 104
Anacor Pharmaceuticals, Inc.0001209191-14-074300
SEC(opens sec.gov)

Companies

Anacor Pharmaceuticals, Inc.SVP, Program Management

Address

1020 EAST MEADOW CIRCLE

PALO ALTO, CA, 94303